More potential fraud in the ivermectin literature - my new piece builds on work by @K_Sheldrick on Brazilian data that looks very strangehttps://gidmk.medium.com/is-ivermectin-for-covid-19-based-on-fraudulent-research-part-2-a4475523b4e4 …
-
Show this thread
-
Replying to @GidMK @K_Sheldrick
Ever since I heard you say quite a few absurd things on the Rebel Wisdom podcast, I have serious doubts about your actual agenda. Having said that, it won't stop me from looking at your findings and taking them seriously, obviously.pic.twitter.com/dHUI0WS1C5
3 replies 0 retweets 2 likes -
-
Replying to @GidMK @K_Sheldrick
1) you start by not answering to the actual argument, which is clearly articulated as "financial interests are trying to suppress ivermectin research". You pretend that the argument is "
@GidMK and error finders are being paid by Big Pharma" and start answering to that instead.2 replies 0 retweets 7 likes -
Replying to @GabinJean3 @K_Sheldrick
I mean, financial interests are quite clearly not trying to suppress ivermectin research, given that there are now some really large trials of the drug being performed and out. And people regularly accuse me of being a paid shill, so it's a useful lie to address
2 replies 0 retweets 8 likes -
"there are now some really large trials of the drug being performed and out." The real question is: are these trials designed to succeed or to fail?
2 replies 0 retweets 0 likes -
You design trials to test a question - succeed or fail is a rhetorical position, not a scientific one
1 reply 0 retweets 3 likes -
Disagree. You design a trial based on what you already know about the question. When you think a medication could have an antiviral activity (I don't speak here specifically about IVM) and test it, you don't recrute late stage patients, unless your goal is to fail.
1 reply 0 retweets 0 likes -
If the claim is "ivermectin can be used to treat mild/moderate COVID-19 patients" which is the claim made by many (FLCCC, BIRD, etc etc etc) then you can test that claim without aiming to fail
2 replies 0 retweets 4 likes -
There are plenty of reasons a trial can fail, we all know it. Underpowered, weak protocol, bad posology, bad choice of outcome, bad choice of population being tested, etc, etc, etc...
1 reply 0 retweets 0 likes
These are reasons that a trial can answer the wrong question - that is not 'failing'. That being said, the Together trial answered the question "does ivermectin reduce the risk of hospitalization/death if given to outpatients with mild disease?" quite admirably
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.